Related references
Note: Only part of the references are listed.Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas
Per Helsing et al.
GENES CHROMOSOMES & CANCER (2008)
Electron microscopy evidence that cytoplasmic localization of the p16INK4A nuclear cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact.: A study in non-small cell lung carcinomas
K Evangelou et al.
BIOTECHNIC & HISTOCHEMISTRY (2004)
Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics
E de Vries et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2004)
Genetic susceptibility in familial melanoma from northeastern Italy
MT Landi et al.
JOURNAL OF MEDICAL GENETICS (2004)
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients
P Ghiorzo et al.
HUMAN PATHOLOGY (2004)
Progression in cutaneous malignant melanoma is associated with distinct expression profiles - A tissue microarray-based study
SR Alonso et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
Å Borg et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
